直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

Valeant Pharmaceuticals NA, LLC v. Zydus Pharmaceuticals, Inc.

Valeant Pharmaceuticals NA, LLC

Zydus Pharmaceuticals, Inc.

Secured a permanent injunction against generic defendant on behalf of Valeant in Hatch-Waxman patent infringement litigation concerning an ANDA for generic versions of Cardizem® LA.

Valeant Pharmaceuticals NA, LLC v. Zydus Pharmaceuticals, Inc., 3:17-cv-00449, D.N.J., Judges Sheridan, Goodman

Related Professionals

Justin J. Hasford
Partner
Washington, DC
+1 202 408 4175
Email
Bryan C. Diner
Partner
Washington, DC
+1 202 408 4116
Email
Matthew J. Hlinka
Partner
Washington, DC
+1 202 408 4333
Email
Christina Ji-Hye Yang
Partner
Washington, DC
+1 202 408 4465
Email

Related Practices

Global IP Enforcement, Litigation, and Trials

Branded Hatch-Waxman (ANDA) Litigation and Trials

Related Industries

Life Sciences

Pharmaceutical

Related Experiences

Valeant Pharmaceuticals Int’l, Inc. v. Mylan Pharmaceuticals, Inc. 

Valeant; Salix; Progenics

Valeant Pharmaceuticals North America, LLC v. Actavis, Inc.

Valeant Pharmaceuticals North America, LLC

Medicis Pharmaceutical Corp. v. Zydus Pharmaceuticals (USA) Inc.

Medicis Pharmaceutical Corp.

Valeant Pharm. N. Am. LLC and Kaken Pharm. Co. Ltd. v. Zydus Pharm. (USA) Inc.

Kaken Pharmaceutical Co., Ltd.

Finnegan secures 10 years of patent protection for Relistor®

Valeant; Salix; Progenics

Dow Pharmaceutical Sciences, Inc. v. Taro Pharmaceuticals U.S.A., Inc.

Dow Pharmaceutical Sciences, Inc.; Valeant

Otsuka Pharmaceutical Co., Ltd. v. Teva Pharmaceuticals USA, Inc.

Otsuka Pharmaceutical Co.

Elan Pharmaceuticals, Inc. v. Ivax Pharmaceuticals, Inc.

Elan Pharmaceuticals, Inc.

Cephalon, Inc. v. Sun Pharmaceuticals Industries, Inc.

Cephalon, Inc.

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP